Tacrolimus and sirolimus reduces de novo anti-HLA antibodies in kidney transplant receptors

被引：0
|
作者：
Morales-Buenrostro, Luis E. [1 ]
Castro, Rene [1 ]
Terasaki, Paul I. [1 ]
机构：
[1] Terasaki Fdn Lab, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [31] Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival
    Redondo-Pachon, Dolores
    Pascual, Julio
    Perez-Saez, Maria J.
    Garcia, Carmen
    Jose Hernandez, Juan
    Gimeno, Javier
    Mir, Marisa
    Crespo, Marta
    TRANSPLANT IMMUNOLOGY, 2016, 34 : 1 - 7
  • [32] Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival
    Guidicelli, Gwendaline
    Guerville, Florent
    Lepreux, Sebastien
    Wiebe, Chris
    Thaunat, Olivier
    Dubois, Valerie
    Visentin, Jonathan
    Bachelet, Thomas
    Morelon, Emmanuel
    Nickerson, Peter
    Merville, Pierre
    Taupin, Jean-Luc
    Couzi, Lionel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (02): : 615 - 625
  • [33] DONOR SPECIFIC ANTI-HLA ANTIBODIES IN TRANSPLANT GLOMERULOPATHY
    Eng, Hooi Sian
    Bennett, Greg
    Tsiopelas, Eleni
    Chang, Sean
    Bardy, Peter
    Russ, Graeme
    Coates, P. Toby H.
    HUMAN IMMUNOLOGY, 2008, 69 : S109 - S109
  • [34] EXTRACORPOREAL REMOVAL OF ANTI-HLA ANTIBODIES IN TRANSPLANT CANDIDATES
    HAKIM, RM
    MILFORD, E
    HIMMELFARB, J
    WINGARD, R
    LAZARUS, JM
    WATT, RM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (05) : 423 - 431
  • [35] Effect of SARS-CoV-2 Infection on Anti-HLA Antibodies and De Novo DSA Incidence in Lung Transplant Recipients
    Zajacova, A.
    Dvorackova, E.
    Vyskocilova, K.
    Casas-Mendez, L.
    Kotowski, T.
    Valentova-Bartakova, L.
    Fila, L.
    Lischke, R.
    Havlin, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S158 - S158
  • [36] The Development of De Novo Anti-hla Antibodies after Heart Transplant is Related to the Development of Rejection Depending of Their Complement Fixing Capability
    Farrero Torres, Marta
    Rigal, Marcelo J. Pando
    Valantine, Hannah
    Smith, Spenser B.
    Khush, Kiran
    CIRCULATION, 2012, 126 (21)
  • [37] DE NOVO DEVELOPMENT OF ANTI-HLA ANTIBODIES IN LUNG TRANSPLANT RECIPIENTS WITH PREEXISTING DSA IS RELATED TO PIRCHE-II SCORE
    Lobashevsky, Andrew L.
    Niemann, Matthias
    Kowinsk, Brenda
    Higgins, Nancy G.
    Roe, David W.
    Hage, Chadi
    HUMAN IMMUNOLOGY, 2019, 80 : 147 - 147
  • [38] Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients
    Zajacova, Andrea
    Dvorackova, Eliska
    Casas-Mendez, Luis Fernando
    Vychytilova, Katerina
    Rakita, Dmitry
    Valentova-Bartakova, Lucie
    Svorcova, Monika
    Slavcev, Antonij
    Fila, Libor
    Lischke, Robert
    Havlin, Jan
    TRANSPLANT IMMUNOLOGY, 2023, 81
  • [39] Development of De Novo Anti-HLA Abs in Kidney Transplant Recipients: Final Analysis of the NIH CTOT02 Study
    Chandraker, A.
    Guleria, I.
    Ikle, D.
    Chin, H.
    Vincenti, F.
    Morrison, Y.
    Bridges, N.
    Harmon, W.
    Sayegh, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 113 - 113
  • [40] LONG-TERM DE NOVO ANTI-HLA ANTIBODY DEVELOPMENT IN KIDNEY TRANSPLANT RECIPIENTS FROM A SPANISH MULTICENTER STUDY
    Asensio, Esther
    Irure, Juan
    Lopez-Hoyos, Marcos
    San Segundo, David
    Marcen, R.
    Morales, J. M.
    Campistol, J. M.
    Seron, D.
    Anaya, F.
    Andres, A.
    Bustamante, J.
    Escuin, F.
    Gonzalez-Molina, M.
    Lampreabe, I.
    Oppenheimer, Federico
    Pallardo, L.
    Arias, Manuel
    HLA, 2017, 89 (06) : 391 - 392
12345